SCHEMBL32688004

SCHEMBL32688004

N#Cc1c(-c2ccc(-c3ccccc3)nc2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ POLB P06746 3/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ ADORA1 P30542 5/20 0.38
▸ ADORA2A P29274 4/20 0.38
▸ ADORA3 P0DMS8 2/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.36
▸ CRHBP P24387 2/20 0.36
▸ CRHR2 Q13324 2/20 0.36
▸ HSD11B1 P28845 1/20 0.36
▸ PIM1 P11309 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SQOR Q9Y6N5 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687986 0.85 KMT2A (0.39) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL32688138 0.84 KMT2A (0.41) KMT2AMEN1POLBTDP1ALDH1A1
SCHEMBL32688247 0.82 ACMSD (0.44) KMT2AALDH1A1HPGDADORA1ADORA2A
SCHEMBL32688056 0.80 MET (0.41) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL32688192 0.80 ALDH1A1 (0.41) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL32688199 0.79 HSD11B1 (0.36) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL32688271 0.79 ALDH1A1 (0.42) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL32688132 0.78 CXCR2 (0.36) KMT2AMEN1POLBALDH1A1HPGD
SCHEMBL32688472 0.76 GRK6 (0.36) KMT2AMEN1ALDH1A1HPGDADORA1
SCHEMBL32688008 0.75 MEN1 (0.42) KMT2AMEN1POLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KMT2A 3400/4885MEN1 4353/4885POLB 508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback